AF |
atrial fibrillation |
ARBs |
angiotensin receptor blockers |
ASA |
aspirin |
BMS |
bare metal stent |
BNP |
brain natriuretic peptide |
CA |
coronary angiography |
CABG |
coronary artery bypass grafting |
CAD |
coronary artery disease |
CCTA |
coronary computed tomographic angiography |
CMRI |
cardiac magnetic resonance imaging |
COVID-19 |
2019 Coronavirus disease |
ClCr |
creatinine clearance |
CT |
computed tomography |
DAPT |
dual antiplatelet therapy |
DES |
drug eluting stent |
ECG |
electrocardiogram |
FoCUS |
focused cardiac ultrasound study |
GFR |
glomerular filtration rate |
GPIIb-IIIa |
glycoprotein IIb/IIIa inhibitors |
HF |
heart failure |
INR |
international normalized ratio |
LMWH |
low molecular weight heparin |
MACEs |
major adverse cardiac events |
METs |
metabolic equivalents |
MI |
myocardial infarction |
NOACs |
non-vitamin K antagonist oral anticoagulants |
NSQIP |
National Surgical Quality Improvement Program |
NT-proBNP |
N-terminal-pro hormone BNP |
PCI |
percutaneous coronary intervention |
RCRI |
Revised Cardiac Risk Index |
SARS-CoV-2 |
severe acute respiratory syndrome coronavirus-2 |
SPECT |
single-photon emission computed tomography |
TTE |
transthoracic color-Doppler echocardiography |
TURP |
transurethral resection of the prostate |
UFH |
unfractionated heparin |
VKAs |
vitamin K antagonists |